by wpadmin | Aug 19, 2020 | News
Tropocells® Medira is pleased to announce the inclusion of the Tropocells® PRP/TRS/PRF range of products. Cellenis® brand will be used exclusively for Aesthetics, while the Tropocells® brand will be used for dental, oral maxillofacial, ENT and wound...
by wpadmin | Oct 31, 2019 | News
For the second year, Cellenis PRP has featured in a study presentation at the American Society for Dermatologic Surgery annual meeting in Chicago. The seminar delivered by Matthew J. Lin, MD, a dermatologist at Icahn School of Medicine at Mount Sinai, focused on data...
by wpadmin | May 21, 2019 | News
Estar Medical has been successful in revoking Regenlab’s original PRP patent in the European Patent Office (EPO) opposition proceedings. This ruling follows a recent judgment by the UK High Court which also found the Regenlab PRP patent invalid for lack of...
by wpadmin | Apr 20, 2019 | News
Medira is very pleased to report that a challenge to its European patent on Cellenis filed by Regen Lab has been revoked as it was found that it ‘lacked novelty and an inventive step’. This follows a similar outcome that was delivered in the US and the...
